Wave Life Valuation
| WVE Stock | USD 15.36 0.82 5.64% |
At this time, the company appears to be undervalued. Wave Life Sciences maintains a prevalent Real Value of $19.07 per share. The last-minute price of the company is $15.36. Our model calculates the value of Wave Life Sciences from examining the company fundamentals such as Return On Asset of -0.28, profit margin of (1.12) %, and Current Valuation of 931 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Wave Life's valuation include:
Price Book 8.0262 | Enterprise Value | Enterprise Value Ebitda (10.12) | Price Sales 24.7272 | Enterprise Value Revenue 9.91 |
Undervalued
Today
Please note that Wave Life's price fluctuation is unstable at this time. Calculation of the real value of Wave Life Sciences is based on 3 months time horizon. Increasing Wave Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Wave stock is determined by what a typical buyer is willing to pay for full or partial control of Wave Life Sciences. Since Wave Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Wave Stock. However, Wave Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.36 | Real 19.07 | Target 33.38 | Hype 14.42 | Naive 15.08 |
The real value of Wave Stock, also known as its intrinsic value, is the underlying worth of Wave Life Sciences Company, which is reflected in its stock price. It is based on Wave Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Wave Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Wave Life Sciences helps investors to forecast how Wave stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Wave Life more accurately as focusing exclusively on Wave Life's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Wave Life's intrinsic value based on its ongoing forecasts of Wave Life's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Wave Life's closest peers. If more than one evaluation category is relevant for Wave Life we suggest using both methods to arrive at a better estimate.
Wave Life Cash |
|
Wave Life Total Value Analysis
Wave Life Sciences is at this time anticipated to have company total value of 931 M with market capitalization of 2.7 B, debt of 25.4 M, and cash on hands of 148.16 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Wave Life fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
931 M | 2.7 B | 25.4 M | 148.16 M |
Wave Life Investor Information
About 14.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.65. Wave Life Sciences had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Wave Life's historical financial statements, Wave Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Wave Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Wave Life has an asset utilization ratio of 30.75 percent. This indicates that the Company is making $0.31 for each dollar of assets. An increasing asset utilization means that Wave Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Wave Life Profitability Analysis
Based on the measurements of profitability obtained from Wave Life's financial statements, Wave Life Sciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Wave Life's ability to earn profits and add value for shareholders.Net Loss | First Reported 2013-12-31 | Previous Quarter -50.5 M | Current Value -53.9 M | Quarterly Volatility 19.7 M |
For Wave Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Wave Life Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Wave Life utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Wave Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Wave Life over time as well as its relative position and ranking within its peers.
Wave Life Earnings per Share Projection vs Actual
By analyzing Wave Life's earnings estimates, investors can diagnose different trends across Wave Life's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Wave Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Wave Life Ownership Allocation
The majority of Wave Life outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Wave Life Sciences to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Wave Life Sciences. Please pay attention to any change in the institutional holdings of Wave Life Sciences as this could imply that something significant has changed or is about to change at the company.Wave Life Profitability Analysis
The company reported the last year's revenue of 108.3 M. Reported Net Loss for the year was (97.01 M) with loss before taxes, overhead, and interest of (65.38 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Wave Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Wave Life and how it compares across the competition.
About Wave Life Valuation
The stock valuation mechanism determines Wave Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of Wave Life. We calculate exposure to Wave Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Wave Life's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 124.5 M | 130.8 M | |
| Pretax Profit Margin | (4.78) | (5.02) | |
| Operating Profit Margin | (5.04) | (5.29) | |
| Net Loss | (4.78) | (5.02) | |
| Gross Profit Margin | (4.97) | (5.22) |
Wave Life Current Valuation Indicators
Valuation refers to the process of determining the present value of Wave Life Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Wave we look at many different elements of the entity such as Wave's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Wave Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Wave Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Wave Life's worth.Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |